KALRAY
5.7.2022 18:02:03 CEST | Business Wire | Press release
Clever Cloud , a European provider of automation and optimization solutions for websites and applications hosting, and Kalray (Paris:ALKAL) (Euronext Growth Paris: ALKAL), a leading provider of a new generation of processors and acceleration cards specialized in Intelligent Data Processing from Cloud to Edge, announce a partnership aimed at strengthening the relationship between the two companies for the deployment of next-generation storage solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220705005197/en/
Clever Cloud, which is currently setting up in a third Parisian data center and strengthening its technical platform, has chosen to partner with French company Kalray and its Flashbox™, a new generation of NVMe storage array that can accommodate up to 24 PCI Express (NVMe) SSDs, for its high-performance storage solution.
PERFORMANCE, RESILIENCE AND OPENNESS
Without a host CPU (Central Processing Unit), the Flashbox™ leverages K200-LP™ accelerator cards featuring the Coolidge™ DPU (Data Processing Unit) that takes advantage of the unique and patented MPPA® (Massively Parallel Processor Array) architecture developed by Kalray. This chip takes advantage of the power of 80 parallel cores and enables data centers adopting NVMe SSD storage to remove bottlenecks and improve performance, while consuming minimal power and resources.
A unique concept on the market today, the Flashbox™ as proposed by Kalray benefits from ultra-fast interfaces and low power consumption. It can deliver up to 12 million IOPS through a 2x 100 Gb/s network interface and is based on market standards such as Storage Performance Development Kit (SPDK), NVMe/TCP or RDMA over Converged Ethernet (RoCEv1/v2). It will eventually be offered by storage vendors using Kalray cards.
"Kalray's solution meets all our needs and the criteria that are important to us, whether in terms of sovereignty, openness, resilience, energy efficiency or performance ," said Quentin Adam, CEO of Clever Cloud.
The Flashbox™ is currently being tested in Clever Cloud's infrastructure and will join its new Paris data center where it will work alongside the latest generation of compute servers Clever Cloud is installing there. It will enable Clever Cloud to offer greater flexibility to its customers in managing storage, but also to support the launch of new offerings.
This is part of the development of Clever Cloud's Storage API, which allows various storage sources, whether local, remote or via third-party cloud service providers, to be simply allocated to the virtual machines that host users' applications. This open, multi-cloud approach is what makes Clever Cloud so successful.
CLEVER CLOUD AND KALRAY: FOR A “MADE IN FRANCE” R&D
Clever Cloud and Kalray are also partnering in several projects where they are working closely together to leverage Kalray's K200-LP™ cards as accelerators to offload Clever Cloud's network layer functionalities or computations related to the protection and redundancy of data stored within Clever Cloud's servers.
"The collaboration with Kalray is not just about two French companies that have an interest in working together, but about two projects that have, at their heart, the creation of value through innovation, where the partnership is also between the technical teams," adds Steven Le Roux, CTO of Clever Cloud .
“We are very pleased to be working with Clever Cloud, with whom we share common values, both in terms of innovation and the philosophy of our solutions, which are designed to be easy to use, flexible, scalable and open.
Kalray has a unique position in Europe in this market of very high-performance and low-power processors. We are proud to be able to build innovative French storage solutions with Clever Cloud and thus contribute to the technological sovereignty of France and Europe” , declares Eric Baissus, President and CEO of Kalray .
The Flashbox™ will be showcased at the upcoming Flash Memory Summit, a major event in the field, from August 2 to 4, 2022, in Santa Clara Convention Center, CA, USA (booth #940).
ABOUT CLEVER CLOUD
Founded in 2010, Clever Cloud is a company based in Nantes, France, and specialized in IT automation. It creates and provides the software building blocks necessary for the flexible deployment of applications on self-service PaaS architectures. Its clients include such major names as Airbus, AXA, Caisse d'Épargne, Cegid, Docaposte, MAIF, McDonald's, Solocal, SNCF, TBWA...
Website: https://www.clever-cloud.com
Latest news: https://www.clever-cloud.com/blog
ABOUT KALRAY
Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is a fabless semiconductor company, a leading provider of a new class of processors, specialized in Intelligent Data Processing from Cloud to Edge. Kalray’s team have created and developed its leading-edge technology and products to help its clients maximize the market possibilities presented by a world dominated by massive, disparate and pervasive data.
Thanks to Kalray’s patented manycore architecture, Kalray’s MPPA® Intelligent Data Processors are natively capable of managing multiple workloads with no bottlenecks to enable smarter, more efficient and energy-wise data-intensive applications. Kalray's offering includes processors, acceleration cards with associated software environment and appliances, allowing its customers to design the best solutions in fast growing sectors such as modern data centers, 5G, AI and Edge Computing, autonomous vehicles and others.
Founded in 2008 as a spin-off of CEA French lab, with investors such as Alliance Venture (Renault-Nissan-Mitsubishi), Safran, NXP Semiconductors, CEA and Bpifrance, Kalray is dedicated through technology, expertise and passion to offer more: More for a smart world, more for the planet, more for customers and developers. www.kalrayinc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220705005197/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom